Capture of Mouse and Human Stem Cells with Features of Formative Pluripotency. by Kinoshita, Masaki et al.
1 
 
Capture of mouse and human stem cells with features of formative pluripotency 
Masaki Kinoshita1,5, Michael Barber1,6, William Mansfield1, Yingzhi Cui2, Daniel Spindlow1,4, 
Giuliano Giuseppe Stirparo1,4, Sabine Dietmann1,7, Jennifer Nichols1,3 and Austin Smith1,2,4,5* 
 
1 Wellcome-MRC Cambridge Stem Cell Institute 
Jeffrey Cheah Biomedical Centre 
University of Cambridge 
Cambridge CB2 0AW 
United Kingdom 
2 Department of Biochemistry 
University of Cambridge 
Cambridge CB2 1GA 
United Kingdom 
3 Department of Physiology, Development and Neuroscience 
University of Cambridge 
Cambridge CB2 3DY 
United Kingdom 
4 Living Systems Institute 
University of Exeter 
Exeter EX4 4QD 
United Kingdom 
 
5 Authors for correspondence: mk704@cam.ac.uk; austin.smith@exeter.ac.uk  
*Lead contact: austin.smith@exeter.ac.uk  
 
Current addresses: 
6  MRC Human Genetics Unit, University of Edinburgh, Edinburgh, EH4 2XU, Scotland, United 
Kingdom 
7 Department of Developmental Biology and Division of Nephrology, Washington University 
















Pluripotent cells emerge as a naïve founder population in the blastocyst, acquire capacity for 
germline and soma formation, and then undergo lineage priming. Mouse embryonic stem (ES) 
cells and epiblast stem cells (EpiSCs) respectively represent the initial naïve and final primed 
phases of pluripotency. Here we investigated the intermediate formative stage. Using minimal 
exposure to specification cues, we derived stem cells from formative mouse epiblast. Unlike 
ES cells or EpiSCs, formative stem (FS) cells responded directly to germ cell induction. They 
colonised somatic tissues and germline in chimaeras. Whole transcriptome analyses showed 
similarity to pre-gastrulation formative epiblast. Signal responsiveness and chromatin 
accessibility features reflect lineage capacitation. Furthermore, FS cells showed distinct 
transcription factor dependencies, relying critically on Otx2. Finally, FS cell culture conditions 
applied to human naïve cells or embryos supported expansion of similar stem cells, consistent 





Mouse embryonic stem (ES) cells correspond to naïve epiblast, a transient population in the 
pre-implantation embryo (Hackett and Surani, 2014; Smith, 2017). As the embryo implants, 
naïve pluripotency transcription factors are down-regulated and ability to form ES cells is lost, 
while transcription factors such as Otx2 and Pou3f1 are up-regulated together with de novo 
methyltransferases Dnmt3a and Dnmt3b (Acampora et al., 2016; Auclair et al., 2014; Boroviak 
et al., 2014; Boroviak et al., 2015; Brook and Gardner, 1997). After this transition epiblast cells 
manifest competence for primordial germ cell induction (Ohinata et al., 2009). Subsequently 
the epiblast becomes progressively regionally fated and molecularly diverse (Beddington and 
Robertson, 1998; Cheng et al., 2019; Lawson et al., 1991; Peng et al., 2016; Peng et al., 
2019). These events are mirrored by ES cells entering into differentiation (Hayashi et al., 2011; 
Kalkan et al., 2017; Mulas et al., 2017). We hypothesise that exit from naïve pluripotency 
heralds a formative conversion that instates competence for both soma and germline induction 
(Kalkan and Smith, 2014; Kinoshita and Smith, 2018; Smith, 2017).  
Cultures termed epiblast-derived stem cells (EpiSC) have been obtained by exposure of 
embryo explants to fibroblast growth factor (FGF) and activin (Brons et al., 2007; Guo et al., 
2009; Tesar et al., 2007). EpiSCs can be derived from all stages of epiblast (Kojima et al., 
2014; Najm et al., 2011; Osorno et al., 2012), but invariably converge on mid-gastrula stage 
phenotypes, generally displaying transcriptome relatedness to primed epiblast of the anterior 
primitive streak (Kojima et al., 2014; Tsakiridis et al., 2014). Thus, culture of epiblast in 
relatively high levels of FGF (12.5ng/ml) and activin (20ng/ml) results in propagation of a form 
of primed pluripotency, which is likely dictated by these strong growth factor signals. 
Notably, EpiSCs are refractory to primordial germ cell induction, unlike E5.5-6.5 epiblast. 
(Hayashi et al., 2011; Murakami et al., 2016; Ohinata et al., 2009). Naive ES cells are also 
unresponsive to germ cell inductive stimuli, unless they are transitioned for 24-48hrs into a 
population termed epiblast-like cells (EpiLCs) (Hayashi et al., 2011; Nakaki et al., 2013). 
EpiLCs are molecularly as well as functionally distinct from both naïve ESCs and EpiSCs 
(Buecker et al., 2014; Hayashi et al., 2011; Kalkan et al., 2017; Smith, 2017). They are 
enriched in formative phase cells related to pre-streak epiblast, but are heterogeneous and 
persist only transiently (Hayashi et al., 2011). 
Here we invested in an effort to capture and propagate stem cells representative of mouse 
post-implantation epiblast between E5.5-E6.0, when the formative transition is expected to be 




Derivation of stem cell cultures from mouse formative epiblast 
We hypothesised that shielding formative epiblast cells from lineage inductive stimuli while 
maintaining autocrine growth and survival signals may stall developmental progression but 
sustain propagation. Nodal, FGF4 and FGF5 are broadly expressed in the early post-
implantation epiblast (Haub and Goldfarb, 1991; Mesnard et al., 2006; Niswander and Martin, 
1992; Varlet et al., 1997) and promote lineage capacitation in mouse ES cells (Hayashi et al., 
2011; Kunath et al., 2007; Mulas et al., 2017; Stavridis et al., 2007). They are therefore 
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candidates for supporting formative pluripotency. However, together with Wnt3 and bone 
morphogenetic proteins (BMPs), these growth factors also drive specification in the gastrula 
(Liu et al., 1999; Winnier et al., 1995). 
We speculated that in a context of Wnt inhibition and absence of BMP, moderate stimulation 
of FGF and Nodal pathways may sustain a formative population. We used the Tankyrase 
inhibitor XAV939 to block canonical Wnt signalling and excluded undefined components such 
as feeders, serum, KSR or matrigel. Autocrine Nodal is known to be down-regulated in vitro 
in the absence of extraembryonic tissues (Guzman-Ayala et al., 2004), therefore we added 
activin A (20ng/ml) as a substitute. E5.5 epiblasts were isolated by microdissection and plated 
intact in individual fibronectin-coated 4-well plates in N2B27 medium under 5% O2 (Figure 1A). 
After 5-6 days, explants were treated with accutase for 5-10 seconds then gently detached, 
fragmented into small clumps, and seeded into fresh 4-well plates. With or without added FGF, 
colonies of tightly packed epithelioid cells grew up that could be passaged further and 
expanded into continuous cell lines (Figure 1A and S1A). In the absence of FGF we observed 
appreciably higher expression of primitive streak markers Brachyury, FoxA2, Eomes and Gsc, 
(Figure S1B, C). Nodal/activin signalling is known to stimulate these genes (Brennan et al., 
2001; Conlon et al., 1994; Takenaga et al., 2007). We titrated activin and found that continuous 
cultures could still be established in the absence of FGF (Figure 1B and S1D). In low activin 
(3ng/ml) plus XAV939 (AloX) we obtained cell lines that could be propagated for more than 20 
passages (Figure 1B, S1D, Supplemental movie 1).  
Cell lines derived in AloX expressed Otx2, consistent with post-implantation identity, but 
showed no expression of T and minimal FoxA2 (Figure 1C, D). They displayed similar levels 
of Pou5f1 (Oct4) mRNA to EpiSCs, slightly higher Sox2, and lower Nanog. (Figure 1C). Upon 
embryoid body formation and outgrowth, we detected germ layer markers indicating multi-
lineage differentiation (Figure 1E).  
These observations suggest that in the absence of other stimuli, limited stimulation of the 
Nodal/activin pathway combined with autocrine FGF activity may suspend cells in the 
formative phase of pluripotency.  
 
Stem cell propagation is facilitated by retinoic acid receptor inhibition and requires 
Nodal pathway activity 
During establishment and expansion in AloX we observed sporadic expression of neural 
lineage markers and appearance of neuronal morphologies. On occasion differentiation was 
extensive and led to loss of cultures. We speculated that retinoids might be acting as neural 
inductive stimuli (Bain et al., 1995; Stavridis et al., 2010). We therefore applied a pan-retinoic 
acid receptor inverse agonist (RARi, BMS 493; 1.0µM) (Figure S1E). Supplementation of AloX 
with RARi, henceforth AloXR, resulted in improved derivation efficiency (Figure S1F), reduced 
ectopic expression of neural specification factors Sox1 and Pax6 (Figure S1E), and stabilised 
long-term cultures. Using AloXR we established nine cell lines from embryos of two different 
strains, 129 and CD1. These lines were all passaged more than 10 times (30 generations) 
with no indication of crisis or senescence. Established cultures expanded slightly slower than 
EpiSCs and similar to ES cells, with routine passaging every 2-3 days at a split ratio of 1/10-
1/15. Chromosome counts showed a majority of diploid cells even at later passages (Figure 
S1G).  Cells were routinely passaged by mild dissociation into small clumps. Survival was 
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poor after dissociation to single cells but addition of Rho kinase inhibitor (ROCKi) (Watanabe 
et al., 2007) enabled reliable clonal expansion.  
Using fluorescent in situ hybridisation we detected a prominent cloud of Xist expression in 
nuclei of a female line (Figure S1H). Up-regulation of Xist is indicative of initiation of X 
chromosome inactivation, a predicted feature of formative epiblast (Mak et al., 2004; Shiura 
and Abe, 2019). 
Mouse ES cells undergo formative transition when withdrawn from 2iLIF (Hayashi et al., 2011; 
Kalkan et al., 2017; Mulas et al., 2017). We applied AloXR during this transition and obtained 
continuously proliferating epithelial cells. Cultures displayed variable levels of heterogeneity 
during the first few passages (Figure S1I) but stabilised within 4-6 passages and subsequently 
expanded similarly to embryo derived FS cells. We replated cultures in 2iLIF, which supports 
clonal propagation of ES cells at high efficiency (Kalkan et al., 2017). All cells died or 
differentiated within a few days, demonstrating complete extinction of ES cell identity. This 
finding is in marked contrast to other reports of “intermediate” pluripotent states, which readily 
revert to ES cells (D'Aniello et al., 2016; Neagu et al., 2020; Rathjen et al., 1999). 
 
Germline and somatic lineage induction in vitro 
In mouse, the formative phase of pluripotency is definitively distinguished from naïve and 
primed phases by competence for germline specification (Hayashi et al., 2011; Ohinata et al., 
2009). We examined the response of embryo-derived AloXR cells to the cytokine cocktail for 
primordial germ cell (PGC) induction (Ohinata et al., 2009). In each of 8 independent lines 
tested we detected the PGC surface marker phenotype CD61+SSEA1+ (Figure 1F). This 
capacity was maintained even in late passage (>P30) cultures. The proportion of marker 
positive cells ranged up to >30% in some experiments, and was generally between 5-25%, 
although one line was consistently less efficient, around 1%. Two lines expanded without RARi 
also produced CD61+SSEA1+ immunopositive cells, albeit at <10% (Figure S1J). In contrast, 
4 AFX EpiSC lines derived from E5.5 epiblast did not yield double positive cells (Figure S1K). 
Furthermore, AFX EpiSCs adapted to culture in AloXR over several passages remained unable 
to produce primordial germ cell-like cells (PGCLC) (Figure S1L).    
To confirm PGCLC identity, we sorted the CD61+SSEA1+ population and verified expression 
of a range of germ cell markers by RT-qPCR (Figure S1M). We also observed co-expression 
of Oct4, Blimp1 and Stella proteins by immunostaining in both AloXR and AloX cultures (Figure 
1G, S1N). Collectively these features constitute recognised hallmarks of mouse PGCLC 
(Hayashi et al., 2011; Ohinata et al., 2005). Based on this competence we designated AloX 
and AloXR cells as formative stem (FS) cells. 
We then investigated directed somatic differentiation of FS cells in comparison with EpiSCs. 
Inhibition of the Wnt pathway shifts the character of EpiSCs towards anterior epiblast identity 
and predisposes them to neuroectodermal fate (Osteil et al., 2019; Tsakiridis et al., 2014). We 
used the Sox1::GFP reporter (Stavridis and Smith, 2003) to quantify neural induction kinetics 
of FS cells and EpiSCs maintained with Wnt inhibition. After transfer into permissive N2B27 
medium, more than 80% of EpiSCs became GFP positive on day 1 compared with only around 
25% of FS cells (Figure 2A). By day 2, however, the GFP+ fraction approached 80% for FS 
cells and by day 3 reached >80% as for EpiSCs. We examined protein expression by 
immunostaining and found that FS cells lagged behind EpiSCs in both down-regulation of Oct4 
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and up-regulation of Sox1, but by day 3 the vast majority were Oct4-negative and Sox1-
positive (Figure 2B). Thus, mouse FS cells have similar capacity to form neuroectoderm as 
EpiSCs but take longer to do so. 
We tested primitive streak-like induction in response to activin and GSK3 inhibition (Burgold 
et al., 2019). We observed substantially higher induction of mesendoderm surface markers 
and gene expression from FS cells than from EpiSCs (Figure S2A-C). Using flow cytometry 
we quantified Flk1+Ecad- lateral mesoderm and Cxcr4+Ecad+ definitive endoderm. We 
detected no induction of either lineage directly from ground state ES cells and only modest 
induction from EpiSCs (Figure 2C and 2E). Across a panel of FS and EpiSC lines induction of 
mesoderm was on average three-fold more efficient from FS cells (Figure 2D), and of 
endoderm four-fold higher (Figure 2F).  
To probe the basis of differential propensity for primitive streak induction we examined the 
response of ESCs, FS cells and EpiSCs to signals operative during gastrulation. Ground state 
ESCs did not up-regulate T in response to any stimulus tested with the exception of very low 
induction by the GSK3 inhibitor CH. EpiSCs also failed to show any appreciable response, 
apart from induction by CH at 6hrs that was not maintained at 24hrs. In contrast, FS cells 
showed sustained up-regulation of T upon treatment with activin, FGF, CH, or, to a lesser 
extent, BMP (Figure 2G). Notably, addition of FGF at only 1ng/ml induced T and FoxA2 
expression in FS cells (Figure S2D) 
Thus, FS cells show rapid and efficient responsiveness to primitive streak inductive cues but 
require 48 hours for full neural specification. These behaviours are distinct from EpiSCs, and 
consistent with a developmental stage of E5.5-6.0 epiblast. 
 
Chimaera colonisation 
EpiSCs (AF) do not normally contribute to blastocyst injection chimaeras unless they have 
been genetically modified to enhance ICM integration or survival (Masaki et al., 2016; Ohtsuka 
et al., 2012; Tesar et al., 2007). We confirmed this finding for AFX EpiSCs derived from E5.5 
epiblast, detecting no mid-gestation chimaeras after blastocyst injection of three lines and 
transfer of 95 embryos. We tested whether FS cells may have higher probability of enduring 
from the E3.5 blastocyst until stage-matched early post-implantation epiblast. Following 
blastocyst injection of three different embryo-derived FS cell lines engineered to express 
mKO2 or GFP we saw reporter expression in multiple E9.5 embryos (Figures 3A, S3A-E). 
Contributions are low to moderate compared with typical ESC chimaeras and tend to be 
patchy rather than evenly dispersed. Nonetheless, colonisation may be spread over multiple 
tissue types, including Sox2 positive putative migratory primordial germ cells (Figure 3B). We 
examined genital ridge contribution at E12.5 and detected mKO2 reporter positive Oct4+ Mvh+ 
primordial germ cells (Figures 3C, S3F, G). By fluorescence imaging we observed 
contributions to three newborn pups. Two of these animals developed to adulthood and one 
was euthanised at P21 due to malocclusion. Post-mortem tissue inspection revealed 
contributions to brain, bone, skin, heart, lung and gut (Figure 3D). In addition, we obtained one 
overt coat colour chimaera (Figure 3E).  
Chimaera formation conceivably might entail reversion of FS cells to naïve status in the 
blastocyst. We therefore inspected embryos 24 hours after injection. FS cells were localised 
to the ICM, but immunostaining showed that in contrast to host naïve epiblast or introduced 
7 
 
ES cells, FS cells did not express the naïve pluripotency specific transcription factor Klf4 and 
retained the formative marker Oct6 (Figure 3E). Therefore, FS cells maintain formative identity 
within the blastocyst environment. 
Chimaera formation by FS cells derived from post-implantation epiblast challenges the 
conclusion from classic embryo-embryo chimaera studies that epiblast cells lose colonisation 
ability entirely by E5.5 (Gardner and Brook, 1997; Gardner et al., 1985). We revisited those 
experiments using a fluorescent reporter to allow sensitive detection of contributions. We 
dissected epiblasts from cavitated E5.5 and pre-streak E6.0-6.25 transgenic embryos 
expressing membrane-bound tdTomato (mTmG). Epiblasts were dissociated using Accutase 
with addition of ROCKi to improve viability and 10 cells injected per blastocyst. We detected 
tdTomato positive cells in 11 out of 91 embryos recovered at E9.5 (Figures 3F, G, S3H-S3L). 
Contributions were typically sparse and interestingly were most frequent in yolk sac mesoderm 
and amnion. In three chimaeras, however, colonization was widespread in the embryo proper 
(Figures 3F, G, S3H). We did not detect any contribution from streak stage (E6.5-7.0) epiblast 
cells (Figure S3L). 
These observations establish that FS cells and primary formative epiblast cells can contribute 
to blastocyst chimaeras, although with lower efficiency than ES or ICM cells.  
 
Transcriptome relatedness to pre-streak epiblast 
For global evaluation of cellular identity we performed RNA-seq. We first compared FS cells 
with ground state ES cells and with EpiSCs cultured in AF or AFX. Principal component 
analysis (PCA) grouped ES cells apart on PC1 while the two types of EpiSCs and FS cells 
were resolved on PC2 (Figure 4A). Differential expression analysis (Log2 fold change > 1.4, 
adjusted P value < 0.05) identified 531 and 266 genes up-regulated and 941 and 168 genes 
down-regulated in FS cells relative to AF and AFX EpiSCs respectively (Figure S4A ad S4B). 
GO term enrichment analysis highlighted “cell adhesion” in FS cells, contrasting with 
gastrulation and development in EpiSCs (Figures S4A,B). We identified 328 genes that are 
up-regulated in FS cells compared with ES cells or either class of EpiSC (Figure 4B), with GO 
term enrichment for “ion transport” and “cell adhesion” (Figure 4C). 
 
We then used a low cell number RNA-seq protocol with deep read depth (Boroviak et al., 
2015) for comparison of FS cells with dissected pre-cavitation (E5.0), early cavitation (E5.5), 
and pre-streak (E6.0) epiblast. Unsupervised hierarchical clustering showed FS cell 
relatedness to E5.5 and E6.0 epiblast, with lower correlation to the pre-cavitation stage (Figure 
4D). EpiSCs, both AF and AFX, were less related to the pre-gastrula epiblast stages. We 
identified 953 differentially expressed genes between FS cells and EpiSCs. This gene set 
clustered published embryo and EpiLC single cell data (Nakamura et al., 2016) by 
developmental trajectory (Figure 4E). Our RNAseq E5.5 and E6.0 epiblast profiles projected 
onto this PCA aligned with E5.5 and EpiLC single cells (Figure 4E). FS cells overlapped with 
EpiLCs, between E5.5 and E6.5 TLo, whereas EpiSCs were positioned with the E6.5 cells. We 
inspected several of the FS cell specific genes (Figure 4B) and detected dynamic expression 
in the embryo single cell data with enrichment at E5.5 (Figures 4F, S4C).  
 
We performed single cell analysis on FS cells and EpiSCs using the Smart2-seq method 
(Picelli et al., 2014). Applying a threshold of 3M reads we examined 326 cells.  FS cells from 
two independent lines formed a single cluster in the PCA plot (Figure 4G), separated from 
8 
 
EpiSCs on PC1. Notably there was no overlap between EpiSCs and FS cells. PC2 separated 
AF and AFX EpiSCs. Measurement of gene expression correlation by Jaccard index showed 
that FS cells are more homogeneous than either class of EpiSC (Figure 4H). 
 
Collectively these analyses indicate that FS cells capture features of pre-streak epiblast and 
EpiLCs, but are less related to later stage epiblast and EpiSCs. 
 
 
Growth factor requirements for FS cell propagation 
As potential autocrine stimuli of self-renewal or differentiation, we evaluated Nodal, FGF and 
Wnt family representation in the FS cell transcriptome data (Figures S4D-F). We found robust 
expression of Fgf5 as expected but also detected several other FGFs at lower levels. 
However, Fgf8 which is active during primitive streak formation (Sun et al., 1999), was lowly 
expressed compared with EpiSCs. FS cells express both Fgfr1 and Fgfr2 (Figure S4D). We 
tested whether FS cell cultures are dependent on FGF signalling by adding specific inhibitors 
of FGF receptors (PD173074, 0.1µM) or downstream MEK1/2 (PD0325901,1µM). Both 
inhibitors caused rapid collapse of FS cell cultures. We conclude that endogenous low-level 
expression of FGFs supports self-renewal, without inducing the primitive streak-associated 
gene expression associated with exposure to exogenous FGF (Figures 2G, S2D).  
 
FS cells express nodal/activin receptors but interestingly present lower mRNA levels for the 
co-receptor Tdgf1 and for Nodal itself than either ES cells or EpiSCs (Figure S4E). We 
investigated further the requirement for nodal pathway stimulation. Addition of receptor 
inhibitors (A83-01 or SB505124) resulted in extensive cell death and differentiation with loss 
of Oct4 and up-regulation of Pax6 (Figures 4I,S4G). Withdrawal of activin also led to reduced 
viability and increased differentiation, indicating that autocrine activity does not provide 
sufficient pathway stimulation. In FS cell medium activin is added at only 3ng/ml compared 
with 20ng/ml typically used for feeder-free culture of EpiSCs. Dosage sensitivity is a well-
known feature of nodal signalling in the mouse embryo (Robertson, 2014). We observed 
markedly less induction of nodal pathway targets in FS cells at 3ng/ml compared to 20ng/ml 
activin (Figure 4J). Furthermore, immunoblotting indicated lower steady state levels of 
phospho-Smad2 in cells passaged in 3ng/ml activin (Figure 4K). These observations are 
consistent with a dose-dependent response to nodal/activin stimulation, whereby low signal 
sustains the formative gene regulatory network and higher signal promotes primitive streak 
specification.  
 
Finally, the observed expression of Fzd receptors and low levels of some Wnts may underlie 
the requirement for inhibition of Wnt signalling to fully suppress differentiation (Figure S4F). 
Consistent with this interpretation we observed that the porcupine inhibitor IWP2 could 
substitute for XAV939 during FS cell maintenance. 
 
Thus, FS cells are maintained by FGF and nodal/activin but are poised to respond to increased 
levels of either signal or of canonical Wnt by entering into mesendoderm differentiation. 
 
Chromatin accessibility in formative stem cells  
We employed the assay for transposase accessible chromatin coupled to deep sequencing 
(ATAC-seq) (Buenrostro et al., 2013) to survey open chromatin in FS cells. Independent FS 
cell samples were well correlated (Figure 5A). We classified sites that exhibit differential 
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accessibility between ES, FS and EpiSCs based on a fold-change enrichment greater than 
two (p-value<0.05). Reorganisation was evident between naïve and formative cells, with 3742 
sites closing, 4259 opening and only 207 shared open sites (Figures 5B,C). In contrast, 
between formative and primed cells, a majority of open sites were shared (3588), while just 
over 1000 became more accessible and a similar number closed. We detected 826 peaks 
specifically enriched in FS cells compared to either ES cells or EpiSCs. These FS cell-specific 
open chromatin regions were also accessible in transient EpiLCs (Figures 5C,D). Nearby 
genes (<1kb) showed no significant GO term enrichment, however (Figure S5A).  
ChIP-seq for histone modifications showed the expected correlation between open chromatin 
and active marks, H3K4me3, H3K4me1 and H3K27Ac (Fig.5E). Regions that were more open 
in naïve and formative cells showed marked enrichment for H3K4me3 and H3K27ac that was 
lost in EpiSCs. Interestingly, active marks were also more highly represented in FS cells than 
in ES cells at loci that opened only in EpiSCs. We surveyed bivalent promoter regions marked 
with both H3K4me3 and H3K27me3 (Azuara et al., 2006; Bernstein et al., 2006). We 
enumerated 2417 bivalent promoters in FS cells, nearly three times the number in ES cells 
(Figure S5B). Many, but not all, of these loci were also bivalent in EpiSCs. Figure S5C shows 
examples of different profiles. Among the FS cell specific bivalent promoters was Prdm14, 
encoding one of the key germ cell determination factors (Nakaki et al., 2013). Promoters for 
other germ cell genes Tfap2c and Prdm1 are also bivalent in FS cells, consistent with being 
poised for expression (Figure 5F). In EpiSCs, however, Prdm14 loses both marks indicating 
the gene is inactivated. This chromatin change may be a decisive feature in the loss of 
competence for PGCLC induction in EpiSCs (Hayashi et al., 2011) 
We also assessed DNA methylation at open chromatin regions using published data for 
EpiLCs and EpiSCs (Zylicz et al., 2015). In EpiLCs all ATAC peaks were hypomethylated. In 
EpiSCs, in contrast, only primed peaks maintained low methylation (Figure S5D).  
Among genes proximal to shared ATAC peaks in FS cells and EpiSCs, we observed marked 
differential expression (Figure 5G). GO term analysis of genes more highly expressed in 
EpiSCs identified enrichment for heart development, multicellular organism development and 
gastrulation (Figure S5E). These included gastrulation-associated genes such as Cer1, Gsc, 
and Pax3. FS cell enriched transcripts were more numerous but comprised genes without 
annotated functions in early development (Table S1).  
We used HOMER (Heinz et al., 2010) to identify transcription factor binding motifs enriched in 
open chromatin regions (Table S2). Core pluripotency factor binding motifs for Oct4 and Oct4-
Sox-Tcf-Nanog were over-represented in all three cell types. ES cell ATAC peaks were also 
enriched for Tfcp2l1 and Prdm14 motifs, while those in EpiSCs featured Gsc, Brachyury, Slug, 
and Eomes motifs (Figures 5H,S5F). Both FS cells and EpiSCs showed increased 
accessibility of AP1/Jun sites. Finally, we noted that FS cell open chromatin showed specific 
enrichment for ETS-domain factor binding motifs. 
 
FS cells and EpiSCs show contrasting dependencies on Etv and Otx2 
Previously we presented evidence linking Etv5, an ETS factor of the PEA3 sub-family, to 
enhancer activation during pluripotency progression (Kalkan et al., 2019). We also showed 
that ES cells lacking Etv5 show diminished ability to make EpiSCs. Here we employed 
CRISPR/Cas9 to generate ES cells deficient for both Etv5 and the related Etv4. Etv4/5-dKO 
cells failed completely to produce EpiSCs upon transfer to AFX and differentiated into 
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fibroblast-like cells (Figure S6A). This phenotype is more severe than for Etv5 mutation alone. 
Somewhat unexpectedly, however, Etv4/5-dKO cells converted to epithelial culture in AloXR 
and subsequently expanded, albeit with persisting differentiation (Figures 6A, S6A). Relative 
to ESCs, naïve factors were down-regulated and post-implantation markers up-regulated, 
including several targets of Etv5 such as Fgf5, Otx2 and Pou3f1 (Figure 6B). We detected no 
compensatory up-regulation of the third PEA3 member, Etv1. Etv4/5-dKO FS cells 
differentiated readily via embryoid bodies and in directed protocols (Figure S6B-E), including 
induction of Blimp1+, Stella+, Oct4+ PGCLC (Figure S6F). However, when transferred to AFX, 
Etv4/5-dKO cells failed to convert to EpiSCs, lost expression of Oct4 within 3 days, and 
differentiated into fibroblasts with aberrant expression of Pou3f1 (Figures 6C,D,S6G). 
Introduction of an Etv5 transgene to Etv4/5-dKO cells restored the ability to convert to EpiSCs 
(Figure 6E-H). These results establish that Etv4 and Etv5 are not essential for lineage 
competence of FS cells yet are required for production of EpiSCs in vitro.  
Otx2 is prominently up-regulated early during formative transition in vivo and in vitro 
(Acampora et al., 2016; Kalkan et al., 2017), and is implicated in redirecting genome 
occupancy of Oct4 (Buecker et al., 2014; Yang et al., 2014). Intriguingly, Otx2 is dispensable 
in both ES cells and EpiSCs (Acampora et al., 2013), but homozygous embryo mutants exhibit 
severe gastrulation phenotypes (Ang et al., 1996). We generated Otx2 KO ES cells and 
investigated conversion into FS cells in AloXR. Epithelial colonies emerged and could be 
expanded for 4-5 passages but continuously differentiated into neural cells (Figure 6I). By 
passage 5 Oct4 and Nanog were downregulated and the majority of cells were positive for 
Sox1 (Figure 6J). Cultures could not be maintained reliably thereafter. In contrast Otx2 mutant 
ES cells could be converted into stable Oct4 positive EpiSCs by direct transfer into AFX 
(Figure 6I), although colonies frequently displayed aberrant expression of Sox1 as previously 
reported (Acampora et al., 2013)(Figure 6J). BMP has been shown to enhance stability of 
Otx2 deficient EpiSCs (Acampora et al., 2013). We added BMP to two Otx2-/- FS cell cultures 
in AloXR but observed no suppression of differentiation (Figure S6H).  
We also mutated Otx2 directly in FS cells and observed that colonies became compact and 
dome-shaped, superficially resembling naive ES cells (Figure 6K,L,M). When replated in 2iL, 
however, Otx2 mutant FS cells did not expand but differentiated or died (Figure S6I). We 
managed to achieve initial clonal expansion of targeted FS cells in AloXR, but 8 out of 8 clones 
subsequently underwent extensive neural differentiation and could not be stably propagated. 
We added BMP to three cultures, but this did not result in stabilisation.  
These results indicate that Otx2 but not Etv4/5 is required for a stable FS cell state, and 
conversely for EpiSCs. 
 
Generation of human FS-like cells 
We explored derivation of FS cells from naïve human pluripotent stem cells (hPSCs) 
(Takashima et al., 2014). We used both chemically reset lines, cR-H9EOS and cR-Shef6 (Guo 
et al., 2017), and embryo-derived HNES cells (Guo et al., 2016). AloX and AloXR were applied 
as for mouse FS cell culture, except that plates were coated with a combination of laminin and 
fibronectin to improve attachment. The domed naïve hPSCs converted to a more flattened 
epithelioid morphology over several days. Cultures could be propagated continuously 
thereafter and exhibited a faster doubling rate than naïve cells, requiring passage every 4 days 
at a split ratio of 1/15 (Figure 7A). Cells in AloXR lost naïve markers (KLF4, KLF17, TFCP2L1) 
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but retained the core pluripotency factor OCT4, with little or no up-regulation of lineage priming 
markers, TBXT or FOXA2, often detected in conventional hPSCs (Figure 7B) (Allison et al., 
2018; Gokhale et al., 2015). They showed gain of SOX11 and OTX2, markers of post-
implantation epiblast in the primate embryo (Nakamura et al., 2016).  
Naïve hPSCs do not respond productively to somatic lineage induction protocols but must first 
undergo formative transition to lineage competence (Guo et al., 2017). This capacitation 
process takes place over several days (Rostovskaya et al., 2019). FS cells in contrast are 
expected to be directly responsive to lineage cues. We applied established protocols for 
differentiation to human FS cells. In response to definitive endoderm induction (Loh et al., 
2014), we observed efficient formation of SOX17 positive cells (Figure 7C), while neural 
induction via dual SMAD inhibition (Chambers et al., 2009) resulted in abundant SOX1 
immunopositive cells (Figure 7D). We also tested paraxial mesoderm differentiation (Chal et 
al., 2016) and detected up-regulation of TBX6 and MSGN1 along with EMT markers such as 
SNAIL1 and ZEB1 (Figure 7E).  
We prepared RNA-seq libraries from three human FS-like cell lines and carried out whole 
transcriptome comparison with naïve and conventional hPSCs (Figure 7F). PCA distinguished 
naive cells on PC1 and separated formative from conventional hPSCs on PC2, similar to the 
analysis of mouse PSCs (Figure 4A). As a reference for in vivo early post-implantation 
development we used data for the non-human primate Macaca fascicularis (Nakamura et al., 
2016). We computed the PCA for Macaca using 9324 expressed orthologous genes (median 
Log2 expression>0.5) onto which we projected the human cell line samples (Figure 7G).  FS-
like cells and conventional hPSCs aligned with post-implantation embryo stages. FS-like cell 
samples were positioned with post-implantation epiblast while conventional hPSCs spread 
further towards early gastrulating cells.  
Single cell transcriptome data has recently been published for human embryos during 
extended culture (Xiang et al., 2019). We used variable genes in the epiblast and primitive 
streak anlage (PSA) stages to compute the PCA for naïve, formative and conventional hPSCs 
and then projected the embryo single cells. The resulting plot shows a similar pattern to the 
Macaca embryo comparison. Naïve cells clustered with pre-implantation epiblast and 
formative cells were next to post-implantation stages. Conventional hPSCs were adjacent to 
FS cells but distributed more towards the PSA cluster (Figure 7H). 
We performed K-means clustering (k=6) between FS-like and conventional PSC cultures 
(Figure S7A). Cluster 1 comprises 369 genes expressed more highly in FS cells than 
conventional hPSCs. The majority of protein-coding genes in this cluster are expressed in 
naïve cells and persist during capacitation (Figure S7B, C). DPPA2, GDF3 and several ZNF 
genes were identified as useful markers expressed in both naïve and formative cells but 
variably low or absent in conventional hPSCs (Figure 7I, S7D). Expression of these ZNF genes 
was detected in human pre- and post-implantation epiblast transcriptome data (Figure 7J). 
KRAB-ZNFs such as ZNF676, ZNF560, and ZNF528 can suppress expression of 
transposable elements (TEs) (Friedli and Trono, 2015). TEs are dynamically expressed in 
early development and highly differential between naïve and primed hPSCs (Friedli and Trono, 
2015; Guo et al., 2017; Theunissen et al., 2016). We examined TE expression in FS-like cells 
and observed a distinct profile compared with naïve or conventional hPSCs (Figure 7K). For 
example, FS-like cells distinctively expressed LTR6A, and retained expression of certain 
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HERVK TEs also expressed in naïve cells, but did not express subsets of SVA family members 
that are prominent in naive cells, nor subsets of HERVH, LTR7C or LTR12C family members 
that are prominent in primed cells (Figure S7E).  
Finally, we investigated application of FS cell culture conditions directly to human ICM explants 
which are known to transition to early post-implantation stages (O'Leary et al., 2012). We 
thawed E5 and E6 blastocysts and cultured for one or two days respectively in N2B27. We 
then isolated ICMs by immunosurgery or manual dissection and plated them intact on 
laminin/fibronectin coated dishes in AloXR with ROCK inhibitor. After 2-4 weeks, primary 
outgrowths were manually dissociated and re-plated. We established three lines from different 
embryos. The embryo derived lines exhibited similar morphology and growth behaviour to 
naïve PSC derived FS-like cells (Figure 7L). G-banded karyotype analysis showed that all 
three expanded lines were diploid (46XX, 20/20) (Fig.S7F). We confirmed relatively 
homogeneous expression of OCT4, SOX2 and NANOG by immunostaining (Figure 7M). 
Expression of naïve-specific transcription factors KLF4 and KLF17 was not detected while 
transcripts were present for several genes that are expressed in naïve and formative cells but 
down-regulated in conventional hPSCs (Figure 7N).  
 
DISCUSSION 
Expandable stem cells that retain high fidelity to staging posts of pluripotency in the embryo 
will be instrumental in harnessing capacity to recapitulate development, create disease 
models, and manufacture therapeutic cells. Stem cells representative of naïve and primed 
pluripotency have been established in mouse and human (Davidson et al., 2015; Nichols and 
Smith, 2009; Rossant, 2015; Rossant and Tam, 2017) but formative pluripotency has only 
been obtained in the form of transient EpiLCs (Buecker et al., 2014; Hayashi et al., 2011; 
Kalkan et al., 2017; Mulas et al., 2017). The findings in this study fill the stem cell gap between 
early and late pluripotency.  
 
Mouse ES cell derivatives with features of late blastocyst or peri-implantation epiblast, such 
as reduced Rex1 or increased Otx2, have been reported previously (D'Aniello et al., 2016; 
Neagu et al., 2020; Rathjen et al., 1999). However, those cells spontaneously reverted to the 
canonical ES cell phenotype when transferred to ES cell culture. Therefore, they remain within 
the naive spectrum. Significantly, the cytokine LIF, which potently promotes mouse ES cell 
identity (Dunn et al., 2014; Smith et al., 1988; Williams et al., 1988), is a key component of all 
these culture conditions. In contrast, FS cells are maintained without LIF and have 
extinguished ES cell identity, in line with the inability of peri-implantation epiblast to form ES 
cells (Boroviak et al., 2014).  
In mouse, a defining functional attribute of formative epiblast is direct responsiveness to 
germline induction, which is lacking in both naïve cells and primed gastrula stage epiblast 
(Ohinata et al., 2009). Conversion of ESCs into transient EpiLC populations generates a 
window of germline competence (Hayashi et al., 2011). However, maintenance of competence 
over many passages is a unique feature of mouse FS cells, signifying stabilisation of a 
transient embryonic state.      
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Mouse FS cells also differ from ES cells and EpiSCs in their contribution to chimaeras. 
Chimaerism is less frequent, to lower levels, and less evenly distributed than typically obtained 
with ES cells. Poorer contributions are not unexpected given the heterochronicity between FS 
cells and E3.5 host blastocysts. Pioneering mouse embryo chimaera studies suggested that 
blastocyst colonisation capacity was lost entirely after implantation (Gardner, 1985). Here, 
using more sensitive detection systems and injecting 10 cells rather than single cells with 
ROCKi to improve viability, we found that formative epiblast cells can contribute to blastocyst 
chimaeras, similarly to FS cells.  EpiSCs in contrast do not generally show any significant 
contribution to chimaeras via blastocyst injection, unless they have been genetically 
engineered (Masaki et al., 2016; Ohtsuka et al., 2012; Tesar et al., 2007). Intriguingly, it has 
been reported that certain EpiSC lines cultured on feeders or serum-coated dishes contain a 
sub-population of cells that are able to contribute to chimaeras (Han et al., 2010; Kurek et al., 
2015). The nature of such cells is unclear, but our results raise the possibility that they may 
represent FS cells co-existing with EpiSCs in those undefined conditions. 
FS cells exhibit distinct signal dependency and responsiveness compared to ESCs or EpiSCs. 
Both mouse EpiSCs and human conventional PSCs are cultured in medium supplemented 
with FGF. Indeed, high FGF (100ng/ml) is considered an essential component of defined E8 
medium for hPSCs (Chen et al., 2011; Cornacchia et al., 2019). FS cells in contrast are 
cultured without FGF supplementation. Notably mouse FS cells respond directly to FGF or 
other stimuli for primitive streak induction by up-regulating T. Consistent with readiness for T 
induction, FS cells exhibit greater propensity to form mesendoderm than EpiSCs. We surmise 
that the relative recalcitrance of EpiSCs to primitive streak induction may reflect adaptation to 
the high growth factor signals that drive their in vitro proliferation. FS cells are also efficient at 
entering the neural lineage but, consistent with an earlier stage of epiblast, do so more slowly 
than EpiSCs. High competence for germline, primitive streak and neural induction are features 
of pre-streak formative epiblast. Whole transcriptome analysis substantiates this identity and 
further confirms that mouse FS cells are related to EpiLCs and distinct from EpiSCs.  
FS cells and EpiSCs show different transcription factor dependencies. FS cells are mildly 
destabilised by deletion of Etv5 and Etv4 but remain expandable and pluripotent, whereas the 
EpiSC state cannot be established without these factors (Kalkan et al., 2019). Whether the 
inability to produce Etv4/5 dKO EpiSCs results from a cryptic change in formative competence 
or reflects a specific function in EpiSCs remains to be clarified. Interestingly, a proportion of 
Etv5 or Etv4/5 mutants proceed through gastrulation (Lu et al., 2009; Zhang et al., 2009). The 
Etv4/5 knockout phenotypes therefore suggest that the in vitro EpiSC state may not be fully 
representative of epiblast progression in vivo (Kojima et al., 2014). Conversely, Otx2, which is 
necessary for in vivo gastrulation (Ang et al., 1996), is not required by ES cells or EpiSCs 
(Acampora et al., 2013) but is indispensable for stable expansion of FS cells. Defective 
formative transition may also underlie the increased neural  differentiation of EpiSCs lacking 
Otx2 (Acampora et al., 2013). 
In FS cells the transcription factor circuitry governing naïve pluripotency (Dunn et al., 2014; 
Takashima et al., 2014) is dismantled, signalling pathways rewired, and chromatin 
accessibility extensively remodelled compared to ES cells. These events indicate a step 
change as cells transition from naïve to formative pluripotency. By contrast, the separation 
between FS cells and primed pluripotent stem cells is blurred, in line with more continuous 
developmental progression. We surmise that the reconfigured gene regulatory network and 
chromatin landscape in formative cells provide the requisite context for signalling cues to 
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induce germ layer and germline lineage specification and for the subsequent unfolding of 
gastrulation. Capture of formative phase cells as self-renewing stem cell cultures should be 
enabling for comprehensive interrogation of the molecular features that confer and effect multi-
lineage potency. 
Limitations of Study 
Although the formative phenotype is reached within 48hrs of ESC withdrawal from 2i, 
generation of stable FS cell lines requires several passages. The inherent asynchronicity of 
exit from naïve pluripotency (Strawbridge et al., 2020) together with imperfect in vitro transition 
conditions result in initial heterogeneity, as also observed for EpiLC formation (Hayashi et al., 
2011; Kalkan et al., 2017). Passaging enriches for FS cells, similar to stabilistaion of EpiSC 
cultures (Guo et al., 2009), but a more streamlined and efficient capture would be 
advantageous for future research. In mouse, FS cells are clearly distinguished from EpiSCs 
by several features, most notably competence for germ cell induction and ability to colonise 
chimaeras via blastocyst injection. Neither of those functional criteria are applicable in the 
human context. Conventional hPSCs share some features with EpiSCs but do not appear to 
be direct equivalents (Lau et al., 2020; Rossant and Tam, 2017). Notably they can be induced 
to form primordial germ cell-like cells (Irie et al., 2015; Sasaki et al., 2015). Chimaera 
contribution cannot be tested in human embryos. At the transcriptome level, human FS-like 
cells differ from populations of conventional hPSCs cultured in E8 or other conditions, but 
these differences are relative rather than absolute. Heterogeneity and hierarchical 
substructure has been described in hPSC cultures (Allison et al., 2018; Hough et al., 2009; 
Hough et al., 2014; Lau et al., 2020; Nakanishi et al., 2019) and we cannot exclude the 
presence of formative stem cells at some frequency. Human FS cells and conventional hPSCs 
may be a continuum spanning post-implantation epiblast progression. It will be valuable in 
future studies to define marker sets and in vitro differentiation behaviours that can better 
distinguish human formative cells from downstream stages in the spectrum of post-naïve 
pluripotency. To this end additional transcriptomic and other data on post-implantation epiblast 
will be important to allow more precise comparison and staging. 
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Figure1. Derivation of stem cell lines from formative epiblast.  
(A) Schematic of cell line derivation from E5.5 epiblast. (B) Image of serially passaged E5.5 
epiblast-derived culture. Scale bar 100µm. (C) RT-qPCR analysis of marker gene expression 
in AloX cells and EpiSCs relative to ES cells in 2iL (=1), normalized to beta-actin. Error bars 
are S.D. from technical triplicates. (D) Immunofluorescent staining of EpiSCs and AloX cultures 
for early lineage markers. Scale bars 150µm. (E) Immunostaining of embryoid body 
outgrowths for germ layer markers, DAPI in blue. Scale bars, 150µm. (F) Flow cytometry 
analysis of PGCLC induction at day 4. (G) Immunostaining of day 4 PGCLC. Scale bars 50µm. 
Figure 2. Lineage potency of FS cells and responsiveness to differentiation cues.  
(A) Neural differentiation assayed by quantification of Sox1::GFP-positive cells. Error bars 
represent S.D. from 4 independent experiments. (B) Immunostaining of FS cells and EpiSCs 
during neural differentiation, DAPI in white. Scale bars, 100 µm. (C) Lateral plate mesoderm 
differentiation and representative quantifications of the Flk1+Ecad- fractions by flow cytometry. 
(D) Average efficiency of Flk1 positive cell production from FS cells and EpiSCs. n = 
independent cell lines assayed. Error bars represent the S.D. **P<0.01. (E) Definitive 
endoderm differentiation protocol and representative quantifications of the Cxcr4+Ecad+ 
fraction. (F) Average proportion of Cxcr4+Ecad+ double positive cells from differentiation of FS 
and EpiSC lines. Error bars represent S.D., *P<0.05. (G) T expression analysed by RT-qPCR 
6h and 24h after transfer into N2B27 medium with the indicated supplements; 2µM XAV939, 
20ng/ml activin A, 10ng/ml BMP2, 12.5ng/ml Fgf2 and 3µM CH. Relative expression is 
normalised to GAPDH. Error bars are S.D. from two independent cell lines and two technical 
replicates. 
Figure 3. Blastocyst chimaera contribution by FS cells and formative epiblast.  
(A) Bright field and fluorescent images of E9.5 embryos generated after blastocyst injection of 
mKO2 reporter FS cells. Scale bar is 1mm. (B) Sagittal section from one chimaera, stained for 
mKO2 and DAPI. Inset B’, mKO2 positive cells in foregut endoderm (yellow arrowheads) and 
cardiac mesoderm (green arrowheads). Inset B’’ (rotated 900), Sox2 immunostaining (white 
arrowheads) in the hindgut region. Scale bars, 200µm (B), 100µm (B’, B”). (C) mKO2 positive 
cells expressing Oct4 and Mvh PGC markers in E12.5 chimaeric gonad. Triple positive cells 
are highlighted with dashed circles. Scare bars, 75µm. (D) Fluorescent images of organs from 
post-natal (P21) chimaera overlaid with 20% opacity bright field image. Scale bars, 2 mm. (E) 
Coat colour chimaera at P14. (F) Blastocysts injected with GFP reporter ES cells or FS cells 
and cultured for 24 hours. ES cells are Klf4+Oct6- (n=11) (F’) whereas FS cells are Klf4-Oct6+ 
(F’’) (n=15). Scale bars, 40µm. (G) E9.5 chimaeras obtained from blastocyst injection of 
mTmG expressing E5.5 epiblast cells. Scale bars, 500µm. (H) Section from left embryo in 
Panel G stained with anti-RFP to visualise membrane-tdTomato, DAPI in blue. Scale bar, 
200µm. 
Figure 4. Whole transcriptome analysis and nodal/activin pathway activity.  
(A) PCA with all genes for ES cells, FS cells and EpiSCs (AFX and AF). (B) Heatmap clustering 
of naïve, formative and primed enriched genes.  (C) GO term analyses based on the genes 
identified in (B). X-axis is -Log(P-Value). Top 6 significant terms are shown (Benjamini 
value<0.05). (D) Heatmap comparison of FS cells and AFX and AF EpiSCs with E5.0, E5.5 
and E6.0 epiblast cells.  (E) Left, PCA with mouse single cell data from embryos and EpiLCs 
(Nakamura et al 2016). Right, samples from (D) were projected onto the single cell PCA. (F) 
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Gene expression patterns of selected FS cell enriched genes identified in (B) coloured on PCA 
from E. E5.5 epiblast cells are highlighted by the dashed circle. (G) PCA using 2000 most 
abundant genes of scRNA-seq data from two FS cell lines and one AFX and one AF EpiSC 
line. (H) Violin plot of Jaccard index analysis of 2,000 most abundant genes shows higher 
correlation between FS cells than EpiSCs. (I) RT-qPCR analysis of FS cells in AloXR (Ctrl) or 
with addition of 1µM A83-01 or 5 µM SB5124, or withdrawal of activin for 2 days. Relative 
expression to beta-actin. Error bars are S.D. from technical duplicates. (J) RT-qPCR analysis 
of FS cells cultured in low (3ng/ml) and high (20ng/ml) activin for two days. Relative expression 
to beta-actin. Error bars are S.D. from technical duplicates. (K) Western blot analysis of 
phospho-Smad2 protein. Cells were passaged once with low (3ng/ml) or high (20ng/ml) activin 
A before collecting protein. 
Figure 5. Chromatin landscape analysis.  
(A) Hierarchical clustering of all ATAC-seq peaks. (B) Peak changes between states. OC; 
open to closed, CO; closed to open, OO; open to open. (C) Heatmaps of differential ATAC-
seq peaks (D) Heatmaps of ATAC-seq peaks from (C) in EpiLCs and EpiSCs derived from 
RgD2 ES cells. (E) Histone modification patterns at ATAC-seq peaks. (F) Genome browser 
screenshots of H3K4me3 and H3K27me3 distribution at Prdm1, Tfap2c and Prdm14 loci. (G) 
Volcano plot showing gene expression fold changes associated with shared ATAC-seq peaks 
between FS cells and EpiSCs. Purple up-regulated in EpiSCs, blue up-regulated in FS cells.  
(H) Transcription factor binding motif enrichments at ATAC-seq peaks. 
Figure 6. Differential requirements for Etv4/5 and Otx2.  
(A) Morphology of Etv4/5 dKO FS cells. (B) RT-qPCR analysis of ES cells (yellow), parental 
(WT) FS cells (blue) and Etv4/5dKO FS cells (purple). Error bars represents S.D. from 
technical duplicates. (C) Morphology of WT and dKO FS cells in EpiSC (AFX) culture medium 
for three days. (D) Time course RT-qPCR analysis of WT and Etv4/5dKO FS cells in EpiSC 
(AFX) culture. Error bars are S.D. from technical duplicates. (E) Morphology of Etv4/5dKO FS 
cells expressing Etv5 transgene. (F) RT-qPCR assay of Etv1, -4 and -5 in Etv5 rescue dKO 
lines. Error bars represents S.D. from technical duplicates. (G) Morphology of rescued dKO 
FS cells in EpiSC (AFX) culture. (H) Time course RT-qPCR analysis of rescued lines. Error 
bar represents S.D. from technical duplicates. (I) Phase images of Otx2 KO ES cells 
transferred to FS cell or EpiSC (AFX) culture conditions for 5 passages.  (J) Immunostaining 
of Otx2 KO cells at p5 in FS cell or EpiSC culture. Two classes of EpiSC colony were observed: 
left, homogenous Oct4 with heterogenous Nanog and Sox1; right, uniformly Oct4, Sox1 and 
Nanog triple positive. (K) Alkaline phosphatase (AP) staining of control, Oct4 and Otx2 KOs 
generated by Cas9/gRNA transfection in FS cells and EpiSCs. Colonies were stained three 
days after replating transfected cells. (L) Morphology of AP positive Otx2 KO FS cells and 
EpiSCs. (M) Representative image of Otx2 KO FS cells before culture collapse. Scale bars 
100µm, except (J) 50µm. 
Figure 7. Human FS-like cells established from naïve ES cells and embryos.  
(A) Morphology of human AloXR cells derived from naïve hPSCs. Scale bar, 100µm. (B) RT-
qPCR expression analysis of marker genes in two human FS cell lines compared with naïve 
and conventional (primed) hPSCs. Error bars represents S.D. from technical triplicates. (C) 
SOX17 immunostaining of hFS cells after endoderm induction. (D) SOX1 immunostaining of 
hFS cells after neural induction. (E) RT-qPCR analysis of hFS cells differentiated into paraxial 
mesoderm for 6 days. Error bars represent S.D. from technical triplicates. (F) PCA of hFS cells 
with naïve and conventional hPSCs computed with 11051 genes identified by median Log2 
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expression >0.5. (G) Projection of human FS cell and conventional PSC samples onto PCA 
of Macaca ICM/epiblast stages computed with 9432 orthologous expressed genes. (H) PCA 
for cell line populations computed using 922 variable genes across epiblast samples from 
human embryo extended culture (Xiang et al., 2019) with projection of embryo single cells. (I) 
FPKM values for naïve-formative specific genes in naïve, formative or conventional hPSCs. 
(J) Boxplots of naïve-formative specific gene expression in human epiblast stages and 
primitive streak anlage (PSA). (K) Heatmap of differentially expressed transposable elements 
between naïve, formative and conventional samples. (L) Morphology of FS cells derived 
directly from human embryo. Scale bar, 100µm. (M) Immunostaining of OCT4, SOX2 and 
NANOG in embryo-derived hFS cells. Scale bar, 250µm (N) RT-qPCR analysis of embryo-






CONTACT FOR REAGENT AND RESOURCE SHARING 
 
Lead Contact 
Further information and requests for resources and reagents should be directed to and will 
be fulfilled by the Lead Contact, Austin Smith (austin.smith@exeter.ac.uk). 
 
Materials Availability 
All stable reagents generated in this study are available from the Lead Contact without 
restriction except for human embryo derived cell lines for which permission must be 
requested from UK Stem Cell Steering Committee and a Materials Transfer Agreement 
completed. 
 
Data and Code 
The datasets reported in this paper are deposited in GEO with the following accession codes: 
RNA-seq and ATAC-seq, GSE131556; scRNA-seq, GSE156589; ChIP-seq, GSE156261 
 
 
EXPERIMENTAL MODEL AND SUBJECT DETAILS 
 
Mice 
Mice used in these studies were adult females aged 6-10 weeks. CD1 and 129aa strains 
provided embryos for cell line derivation and ROSAmT/mG mice provided donor embryos for 
primary epiblast injections. Host embryos for chimaera generation were from C57BL/6. 
CBA/BL6 F1 animals were used as transfer recipients. Animals in the facility tested positive 
for Helicobacter and negative for other specific pathogens. Studies were carried out in a UK 
Home Office designated facility in accordance with EU guidelines for the care and use of 
laboratory animals, and under authority of UK Home Office project licence 76777883. Use of 
animals in this project was approved by the Animal Welfare and Ethical Review Body for the 
University of Cambridge.  
 
Human Embryos 
Supernumerary frozen human embryos were donated with informed consent by couples 
undergoing in vitro fertility treatment. Use of human embryos in this research is approved by 
the Multi-Centre Research Ethics Committee, approval O4/MRE03/44, and licensed by the 
Human Embryology & Fertilisation Authority of the United Kingdom, research license R0178. 
 
Cell Cultures 
Cell lines are listed in the Key Resources Table. Cell lines were cultured without antibiotics in 
humidified incubators at 37˚C in 7% CO2. Reduced oxygen (5%) was used except for mouse ES 
cells, which were maintained in atmospheric oxygen. Cell lines tested negative for 
mycoplasma by periodic PCR screening. 
Mouse FS cell, EpiSC and ES cell culture 
FS cells were cultured in AloXR medium, comprising 3ng/ml of activin A, 2µM XAV939 and 
1.0µM BMS439 in N2B27 medium (Nichols and Ying, 2006). EpiSCs were cultured in either AF 
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(20ng/ml activin A and 12.5ng/ml Fgf2) or AFX (20ng/ml activin A, 12.5ng/ml Fgf2 and 2µM 
XAV939) in N2B27 medium. When passaging, cells were dissociated by Accutase into clumps 
and re-plated every 2-3 days at a ratio of 1:10-1:20. Mouse ES cells were maintained in 2i/LIF 
medium as described (Mulas et al., 2019). FS cells and EpiSCs were maintained on fibronectin 
(Fn) coated (16.7 µg/ml) plates. Experiments were generally performed between p10 and p30. 
Derivation of FS and EpiSCs from mouse embryo 
E5.5 mouse embryos were dissected from decidua and further micro-dissected into 
embryonic and extraembryonic parts. Extra-embryonic endoderm layers were removed by 
mouth pipette and individual epiblasts were plated onto Fn coated (16.7 µg/ml) 4-well plates 
in either FS or EpiSC medium. After the epiblast outgrowth became large enough, the 
outgrowth was briefly incubated in Accutase and collected in wash buffer and re-plated onto 
a fresh 4-well plate.  
Derivation of FS and EpiSCs from mouse ES cells 
ES cells were plated either directly in AloXR, AF or AFX medium or N2B27 basal medium for 
two days and then re-plated in AloXR, AF or AFX medium. Cultures were passaged at higher 
densities for the first 4-5 passages with Accutase.  
Derivation of human FS cells from naïve PSCs 
Human naïve PSC propagated in PXGL (Bredenkamp et al., 2019) were cultured in N2B27 
medium for 7 days before changing to AloXR. Cells were passaged every 3-5 days at a ratio of 
1:10-1:20 and Rock inhibitor was added for the first 24 hours after dissociation. hFS cells were 
cultured on plates pre-coated with Laminin (10 µg/ml) and Fn (16.7 µg/ml).  
Derivation of human FS cell from embryos 
Day 5 or day 6 human embryos were thawed using SAGE REF ART 8030 vitrification warming 
kit as per the manufacturer’s instructions and cultured for one or two days in N2B27 basal 
medium in 7% CO2 and 5% O2 at 37˚C. ICMs were isolated on the following day by 
immunosurgery (Solter and Knowles, 1975) or mechanical dissociation and plated in AloXR in 
the presence of Rock inhibitor on laminin/Fn coated 4-well plates. 2-4 weeks later, 
outgrowths were mechanically dissociated into clumps and replated into a fresh well. After 





Embryoid body differentiation 
2,000 cells were plated in low-binding 96-well plates in GMEM supplemented with 10% fetal 
calf serum, 2 mM L-glutamine, 0.1mM Non-essential Amino Acid (NEAA) (GIBCO), 1mM 
Sodium Pyruvate and 0.1mM 2-ME. After 5 days, the EBs were transferred for outgrowth onto 
gelatin-coated plates in fresh medium. 
 
PGCLC differentiation 
3,000 cells were plated in low-binding 96-well plates in GK15 medium (GMEM and 15 % 
Knockout Serum Replacement (GIBCO), 0.1 mM NEAA (GIBCO), 1mM Sodium Pyruvate, 2mM 
L-Glutamine, 0.1mM 2-mercaptoethanol) supplemented with 500 ng/ml BMP2, 100ng/ml 






Mesoderm induction  
Mouse FS cells were plated with 20ng/ml activin A and 3µM CH in N2B27 for 48 hours on Fn 
coated plates. Human FS cells were plated with 3µM CHIR99021 and 500 nM LDN193189 for 
the first 2 days followed by the addition of 20ng/ml of Fgf2 from day 3 to day 6. 
 
Endoderm induction  
Mouse FS cells were plated with 20ng/ml activin A and 3 µM CH in N2B27 for 24 hours and 
the medium was replaced thereafter with 20ng/ml of activin A only for a further 2 days on Fn 
coated plate. Human FS cells were differentiated in 100ng/ml activin A, 100nM PI-103, 3µM 
CH, 10ng/ml Fgf2, 3ng/ml BMP4 and 10µg/ml Heparin for the first 24hrs and then replaced 
with 100ng/ml activin A, 100nM PI-103, 20ng/ml Fgf2, 250nM LDN193189 and 10 µg/ml 
Heparin for a further 2 days.  
 
Neural induction 
Mouse FS cells were plated on laminin coated plates in N2B27 (Mulas et al., 2019). Human FS 
cells were plated with 1µM A83-01 and 500nM LDN193189. 
 
Signal responsiveness  
Cells were plated in self-renewal medium and cultured overnight. On the following day, 
medium was changed to N2B27 medium with or without growth factors/inhibitors. The 
concentrations used were, activin A (20 ng/ml), Fgf2 (12.5 ng/ml), CHIR99021 (CH, 3µM), 
Bmp2 (10 ng/ml), XAV939 (2 µM). 
 
Flow cytometry analysis 
Mouse endoderm and mesoderm cells were dissociated with Cell Dissociation Buffer (GIBCO). 
mPGCLC were dissociated with TripLE Express (GIBCO). After the dissociation, cells were 
incubated with fluorophore-conjugated antibodies in rat serum on ice for 20 min. Cells were 
washed once with wash buffer and analysed in HANK’s buffer supplemented with 1 % BSA. 
Antibodies are listed in the Key Resource table. 
 
RT-qPCR 
Total RNAs were purified by Reliaprep RNA miniprep kit (Promega). cDNAs were prepared by 
GoScript reverse transcription system (Promega). PCR was performed by Taqman Gene 
Expression Master Mix (Thermo Fisher Scientific) with Taqman (Thermo Fisher Scientific) or 
Universal Probe Library (Roche) probes. Probes and primer information are listed in Table S3. 
 
Immunofluorescence analysis 
Cells were fixed on plates in 4% PFA for 15 minutes at RT. Cell were blocked with 5% skimmed 
milk or BSA/PBS 0.1 % TritonX. Primary and secondary antibodies were incubated for 1 hour 
at RT or overnight at 4˚C. Antibodies used were listed in key resource table. Cells were imaged 
by LeicaDMI4000. PGCLCs and embryo sections were imaged by Leica SP5.  
 
FISH for Xist 
FS cells were plated on Fn coated glass slide (Roboz Surgical instrument). The fluorescent 
conjugated RNA probe was purchased from Stellaris (Biosearch Technologies). Xist FSIH was 
performed as described previously (Sousa et al., 2018). Nuclear was stained with Dapi and 




Metaphase chromosome analysis 
FS Cells were treated with KaryoMAX colcemid (Gibco) and cultured further 2.5 hours. Cells 
were washed with PBS and harvested by Accutase and collected in wash buffer. After 
centrifuge, cells were resuspended in 5 ml of pre-warmed 0.075M KCl and incubated for 15 
minutes at RT. Freshly prepared ice cold fixative solution (methanol: glacial acetic acid (3:1)) 
(100 µl) were added into the suspension and centrifuge. Cells were resuspended in 250-500 
µl of fixative solution and up to 20 µl was spread onto a glass slide. DNA was counterstained 
with DAPI and spreads were imaged by Leica DMI4000 for counting. Karyotype analysis of 
embryo derived hFS cell lines were performed by Medical Genetics Service, Cytogenetics 
Laboratory, Cambridge University Hospitals. 
 
Immunoblotting 
Culture plates were taken out from the incubator and placed on ice. Cells were washed with 
ice-cold PBS and lysed with RIPA buffer in the presence of Protease/Phosphatase inhibitor 
cocktail (Invitrogen). Lysed cells were rotated for 20 minutes and sonicated in Bioruptor 
(Diagenode). Cell lysates were cleared by centrifugation, and the supernatant was recovered. 
Protein concentrations were measured by the BCA method (Pierce). 25 µg of protein was 
loaded in each well. Blots were blocked with 5% BSA/TBS 0.1 % Triton-X for 1 hour at RT and 
incubated overnight with primary antibodies at 4˚C. Secondary antibodies were incubated for 
1 hour at RT and signals were detected with ECL Select (GE Healthcare) and Odyssey Fc (Li-
Cor). NaOH (0.2N) was used for stripping. 
 
Etv4/5 and Otx2 knock out analysis 
Etv4/5 dKO ES cell lines were established from Etv4 KO ES cells (Kalkan et al., 2019) using a 
CRISPR/Cas9 based method. gRNAs were designed to excise Ets domain of Etv5 in Exon13 and 
Exon15. Otx2 KO ES cell lines were established from E14tg2a ES cells. gRNAs were designed 
to excise homeobox in Exon3. gRNAs were cloned into pCML32. Targeted ES cell clones were 
picked and genotyped by genomic PCR. Oct4 and Otx2 KO in FS cells were performed by co-
transfected with one gRNA expression plasmid (pCML32, Oct4-1, Otx2-1 in Table S3, 
puromycin resistance, piggyBac vector) with Cas9 expressing plasmid (G418 resistance,  
piggybac vector) and PBase expressing plasmid by TransIT LT1 (Mirus). Transfected cells were 
selected with 1 µg/ml of puromycin and 250 µg/ml of G418 from 24-48 hours post-
transfection. Cells were counted and re-plated for another three days to form colonies. Rock 
inhibitor was added for the first 24 hours after replating. Alkaline phosphatase staining was 
performed following manufacture’s instruction (Sigma-Aldrich). gRNA sequences, genotyping 
primers and the amplicon sizes of each genotypes are listed in Table S3. 
 
RNA-sequencing 
For the bulk RNA-sequencing experiment, cells were lysed in Trizol (Thermo Fisher Scientific) 
and total RNAs were prepared using the PureLink RNA Mini Kit (Thermo Fisher Scientific). 
Ribosomal RNAs were removed by Ribo-Zero rRNA Removal Kit (Illumina) and libraries were 
constructed using the NEXTflex Rapid Directional RNA-seq Kit (Bioo Scientific). For the low-
input RNA-sequencing experiment, RNA was isolated from cells and epiblasts with the 
PicoPure RNA Isolation kit (Thermo Fisher Scientific) and libraries were constructed using the 
SMARTerR Stranded Total RNA-Seq Kit v2- Pico InputMammalian (Takara Clontech). 1,000 FS 





50,000 cells were collected and washed with ice-cold PBS once then lysed in lysis buffer (10 
mM Tris-HCl, pH  7.4, 10 mM NaCl, 3 mM MgCl2, 0.1% IGEPAL). The nuclear pellets were 
collected and Tn5 tagmentation and library construction performed using the Illumina 
Nextera kit  (FC-121-1030). DNA was purified with AMPure XP beads (Beckman Coulter). 
 
ChIP-seq  
ChIP was performed following the protocol reported previously (Kalkan et al., 2019). Briefly, 
chromatin was cross-linked with 1% formaldehyde for 10 minutes at RT and quenched with 
125 mM Glycine for 5 minutes at RT with rotation. After cell pellets were lysed, sonication 
was performed for 16 cycles on High setting, 30sec ON/30 sec OFF cycle by Bioruptor 
(Diagenode), 2x107 cells per 300 µl in Bioruptor tube. 10% inputs were collected for the later 
library construction. Chromatin was immunoprecipitated with 2 µg of each antibodies and 20 
µl of Protein G Dynabeads (Invitrogen) were used against 3x106 cells. After the washes, DNA 
was eluted and each samples were treated with 2.5 µg/ml RNase A at 37˚C for 30 minutes 
followed by 87.5 µg/ml Proteinase K at 55˚C for 1 hour. DNA was purified with PCR clean-up 




Cells were directly sorted into each well of 96-well plate filled with 2.3 µl of lysis buffer (1 
unit/µl of SUPERaseIN RNase inhibitor (Invitrogen), 0.2 % Triton X) by BD FACSAria Fusion (BD 




FS cell chimaeras 
FS cells were pre-treated with 10 µM Rock inhibitor for 1 hour before harvesting.  Around 10 
singly dissociated cells were injected into each blastocyst stage embryo. Embryos are either 
transferred into pseudo-pregnant mice or cultured in vitro for another 24 hours in N2B27. 
E9.5 mid-gestation stage embryos and juvenile mouse tissues were imaged by Leica stereo 
microscope. For sectioning, embryos and E12.5 gonads were replaced with 20% sucrose/PBS 
overnight at 4˚C after the fixation then embedded in OCT compound and sectioned at 8 µm 
thickness. Sections were imaged by Zeiss apotome microscope or Leica SP5 confocal 
microscope. 
Epiblast chimaeras 
Homozygous mTmG mice were crossed with CD1 mice to obtain embryos. E5.5, 6.0-6.25 and 
E6.5 embryos were dissected from decidua and separated into embryonic and 
extraembryonic halves. Extraembryonic endoderm layers were removed using a mouth-
controlled pulled Pasteur pipette. Isolated epiblasts were treated with Accutase at room 
temperature and washed with M2 medium in the presence of 10 µM Rock inhibitor. Ten 
dissociated cells were injected per E3.5 blastocyst stage embryo of strain C57BL/6. 
Microinjection was performed in M2 medium containing Rock inhibitor. For sectioning, 
embryos were embedded in OCT compound and sectioned at 10µm thickness. Sections were 




QUANTIFICATION AND STATISTICAL ANALYSIS  
 
Bulk RNA-seq analysis 
Low-quality RNA-seq reads and adaptor sequences were removed using Trim Galore!. Reads 
were aligned to the mouse (GRCm38/mm10) and human (GRCh38/hg38) reference genomes 
using TopHat2 with parameters “ –read-mismatch 2 –max-multihits 1 –b2-sensitive” 
considering uniquely mapping reads only. Gene counts were obtained using featureCounts 
using ENSEMBL (release 89) gene annotations.  Normalization and differential expression 
analyses were performed using the R/Bioconductor DESeq2 package. Normalized counts were 
transformed into log2 fragments per million (FPKM). Genes with log2 fold change>1.6 and 
adjusted p-value <0.05 were considered differentially expressed. Differentially expressed 
gene clusters for human cells were identified by k-means clustering of the first five principal 
components using the R ‘kmeans’ function. The distance plot was calculated using Euclidean 
distance between samples based on log2 normalized counts of expression values.  Heatmaps 
were generated using the R ‘pheatmap” function. 
 
For transposable elements (Tes), reads were aligned to the human (GRCh38/hg38) reference 
genome using bowtie with parameters “-a –best –strata -m 1 -v 2”, retaining uniquely 
mapping reads only in order to identify the genomic origin of TE transcription. Read counts 
on Tes were obtained using featureCounts on UCSC RepeatMasker-annotated regions. 
Normalization and differential expression analyses between cell types of identical genotype 
were performed with the R/Bioconductor DESeq package. Tes with an expression of at least 
log2-normalized counts > 3.5 in any cell type, a log2 fold change>2 and an adjusted p-value 
<0.05 were considered differentially expressed. 
 
Published RNA-seq data comparison analysis 
Mouse single cell RNA-seq data was downloaded from Nakamura et al., 2016 (GEO: 
GSE74767). Human naïve and conventional PSC transcriptome data were downloaded from 
SRA: SRP104789, ENA:E-MTAB-5114, ENA:E-MTAB-5674,  GEO:GSE123005. The data was 
processed using the same methods as described above, except that genes with zero counts 
were removed from the single cell RNA-seq data matrix before further processing by DESeq2. 
The matrix of log2 fragment per millions for the Macaca fascicularis was obtained from GEO: 
GSE74767 (Nakamura et al., 2016). The Human single cell RNA-seq FPKM 24ummarized 
counts matrix was downloaded from GEO: GSE136447 (Xiang et al., 2019).  
 
PCA plots 
Principal component analyses (PCA) were performed using the R ‘prcomp’ function based on 
log2-transformed Z-score expression values. To compare mouse and human bulk RNA-seq 
with mouse and macaque single cell RNA-seq, the principal components of the single cell RNA-
seq data were calculated, with the bulk RNA-seq data projected onto this PCA space using the 
R ‘predict’ function. These PCAs were computed using all expressed genes or with genes 
differentially expressed between the formative and primed lines in order to narrow down 
genes important for developmental progression. To compare human bulk RNA-seq with 
human single cell RNA-seq data, Log2 transformed counts were used. Using the most variable 
genes across the single cell stages, a PCA of the bulk samples was computed and the single 





Raw files were quality controlled using FastQC v0.11.3 and results 25ummarized with MultiQC, 
with checks including distributions of nucleotide content and sequencing depth. Reads were 
aligned to the M.musculus GRCm38.p6 reference genome with Ensembl v98 annotations 
using STAR v2.7.3a (--outSAMtype BAM SortedByCoordinate). Protein-coding gene 
quantification was done using Subread featureCounts v2.0.0 with Ensembl v98 annotations; 
only uniquely mapped reads were used. Cells with fewer than 3M reads were removed from 
further analysis, leaving 326 cells that passed the threshold. Raw expression levels were 
normalized using sctransform (Hafemeister and Satija, 2019), and the PCA created using the 
2000 most abundant genes across the data. Jaccard similarity indices were calculated on the 




Gene ontology (GO) term enrichment analyses were performed using the David tool. 
 
ATAC-seq 
Reads were quality-trimmed using Trim Galore!, and reads shorter than 15 nt were discarded. 
Reads were aligned to the mouse reference genome (GRCm38/mm10) using bowtie with 
parameters “-m1 -v1 –best –strata -X 2000 –trim3 1”. Duplicates were removed using Picard 
tools. Reads longer than one nucleosome length (146 nt) were discarded, and an offset of 4 
nts was introduced. Peaks were called with MACS2 and parameters “–nomodel –shift -55 –
extsize 110 –broad -g mm –broad-cutoff 0.1”. Bigwig files for visualization on the UCSC 
Genome browser were generated using deeptools bamcoverage with parameters “–binSize 
10 and –normalizeUsing RPKM”. ATAC peaks specific to each cell type were identified using 
edgeR within the R/Bioconductor DiffBind package using the option “bNot = T” to allow for 
contrasts between each cell type against all others. Significant peaks were determined using 
a log2 fold change of > 1 and FDR < 0.05.  Heatmaps of ATAC-seq peaks were generated with 
deeptools plotHeatmap. DNA motif enrichment analyses for cell type-specific ATAC-seq peaks 
was performed using HOMER.  
 
BS-seq 
Whole genome BS-seq data was obtained from Zylicz et al., 2014 (GEO: GSE70355).  BS-seq 
reads were aligned to the mouse reference genome (GRCm38/mm10) and deduplicated using 
Bismark.  MethPipe was used calculate methylation levels at each CpG, and only CpGs with at 
least 5X read coverage were retained for further analyses. Methylation levels were averaged 
using a 250nt-sliding window to generate bigwig files.  
 
ChIP-seq  
Raw files were quality controlled using FastQC v0.11.3 and results summarised with MultiQC, 
with checks including distributions of nucleotide content, sequencing depth and adapter 
contamination. Reads were aligned to the M.musculus GRCm38.p6 reference genome using 
bwa mem v0.7.10-r789 (default parameters); the MT, X, Y chromosomes and scaffolds were 
excluded from the resulting BAM files. Genome browser tracks for the UCSC genome browser 
were created with deepTools bamCoverage v3.3.1 (—binSize 30). Averaged genome browser 
tracks for ChIP profile visualization were created as follows: first the tracks were generated 
with bamCoverage (—binSize 5 –normalizeUsing RPKM), then the output was averaged using 
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wiggletools v1.2.1 (Zerbino et al., 2014). Profiles of the ChIP tracks on the ATAC peaks were 
created using deepTools computeMatrix (reference-point --binSize 5 -b 4000 -a 4000 --
referencePoint center) and plotProfile (default parameters). To identify bivalent promoters, 
peak regions were called with macs2 v2.2.6 (-f BAMPE -q 0.05), only peaks with signalValue>5 
were considered for downstream analysis. Peak regions were intersected per condition and 
across histone marks using bedops v2.4.38. HOMER v4.10 was used to calculate distance 
between peaks and transcription start sites (mm10 -size 3000); peaks within 3kb of a TSS were 
considered as promoter peaks.  
 
 
KEY RESOURCES TABLE 
REAGENT or RESOURCE SOURCE IDENTIFIER 
Antibodies 
Mouse monoclonal anti-Oct3/4 (C-10)  Santa Cruz Cat#SC-5279; 
RRID:AB_628051 
Goat polyclonal anti-Oct3/4 (N-19) Santa Cruz Cat#SC-8628; 
RRID:AB_653551 
Goat polyclonal anti-Brachyury  R&D systems Cat#AF2085; 
RRID:AB_2200235 




Rabbit polyclonal anti-Stella/Dppa3 Abcam Cat#ab19878; 
RRID:AB_2246120 
Rat monoclonal anti-Blimp1/Prdm1 Santa Cruz Cat#SC-47732; 
RRID:AB_628168 
Mouse monoclonal anti-Foxa2 Abnova Cat#H00003170-
M10; 
RRID:AB_534871 
Mouse monoclonal anti-Tuj1 R&D systems Cat#MAB1195; 
RRID:AB_357520 
Mouse anti-cardiac Troponin T (1C11) Abcam Cat#Ab8295; 
RRID:AB_306445 
Goat polyclonal anti-Sox17 R&D systems Cat#AF1924; 
RRID:AB_355060 
Goat polyclonal anti-Gata4 Santa Cruz Cat#SC-1237; 
RRID:AB_2108747 
Rabbit polyclonal anti-Eomes Abcam Cat#ab23345; 
RRID:AB_778267 
Rat monoclonal anti-Ecadherin (ECCD2) Kind gift from Prof. M 
Takeichi 
N/A 
Rat monoclonal anti-Nanog eBioscience Cat#14-5761-80; 
RRID:AB_763613 
Rat monoclonal anti-Sox2 eBioscience Cat#14-9811-82; 
RRID:AB_11219471 
Mouse monoclonal anti-Oct6 (Pou3f1) Miilipore Cat#MABN738; 
RRID:AB_2876862 
Rabbit polyclonal anti-mKusabira Orange MBL Cat#PM051M; 
RRID:AB_2876863 
Alexa Fluore 647 anti-SSEA1 BD Bioscience Cat#562277; 
RRID:AB_11154583 
PE Anti-mouse/rat CD61 Biolegend Cat#104307; 
RRID:AB_313084 
Anti-CD324 (Ecadherin) eFluor-660 eBioscience Cat#50-3249-82; 
RRID:AB_11040003 




APC Anti-mouse CD184 (Cxcr4) Biolegend Cat#146508; 
RRID:AB_2562785 
PE Anti-Flk1 Biolegend Cat#136403; 
RRID:AB_1967093 
Rabbit anti-RFP Rockland Cat#600-401-379; 
RRID:AB_2209751 
Rabbit anti-mvh Abcam Cat#ab13840; 
RRID:AB443012 




Mouse anti-total Smad2/3 BD Bioscience Cat#610842; 
RRID:AB_398161 
Mouse anti-Gapdh Sigma-Aldrich Cat#G8795; 
RRID:AB_1078991 
Rabbit anti-H3K4me1 Abcam Cat#ab8895; 
RRID:AB_306847 
Rabbit anti-H3K4me3 Diagenode Cat#C15410003; 
RRID:AB_2616052 
Rabbit anti-H3K27Ac Active Motif Cat#39135; 
RRID:AB_2614979 
Rabbit anti-H3K27me3 Merck Cat#07-449; 
RRID:AB_310624 
   
Bacterial and Virus Strains  
   
Biological Samples   
   
Chemicals, Peptides, and Recombinant Proteins 
XAV939 Sigma Aldrich X-3004 
BMS493 Tocris Bio-Techne 3509 
A83-01 Generon A12358-50 
SB-505124 Selleckchem S2186 
LDN193189 Axon Medchem Axon 1509 
PD0325901 abcr AB 253775 
CHIR99021 abcr AB 253776 
Y27632 Millipore Cat 688000 
Recombinant Mouse LIF In house N/A 
Recombinant human LIF In House N/A 
Recombinant human activin A Qkine Qk005 
Recombinant zebrafish Fgf2 Qkine Qk002 
Recombinant mouse Stem Cell Factor BioLegend 579706 
Recombinant human BMP2 In House N/A 
N2 Supplement In house N/A 
B27 Supplement Thermo Fisher 
Scientific 
17504044 
Neurobasal Thermo Fisher 
Scientific 
11540566 
DMEM/F12 Thermo Fisher 
Scientific 
21103049 
Human Plasma Fibronectin Millipore FC010 
Tissue culture Laminin Millipore CC095-5MG 
Gelatin Sigma-Aldrich G-1890 
Accutase Biolegend 423201 
M2 medium Sigma-Aldrich M-7167 
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Critical Commercial Assays 
NEXTflex Rapid Directional RNA-seq Kit Bioo Scientific 5138-08 
Ribo-Zero rRNA Removal Kit Illumina MRZH11124 
PureLink RNA Mini kit Thermo Fisher 
Scientific 
12183018A 
PicoPure RNA Isolation kit Thermo Fisher 
Scientific 
KIT0214 
SMARTerR Stranded Total RNA-Seq Kit v2 – Pico 
InputMammalian 
Takara Clontech 634412 
Nextera DNA Library Preparation Kit Illumina FC-121-1030 
SAGE Warming Kit CooperSurgical 


















TransIT LT1 Mirus MIR2304 
Alkaline Phaphatase Kit Sigma Aldrich 86R-1KIT 
   
   
Deposited Data 
RNA-seq This paper GSE131566 
ATAC-seq This paper GSE131566 
scRNA-seq This paper GSE156589 
ChIP-seq This paper GSE156261 
   
Experimental Models: Cell Lines 
5ar1 (mFS) This paper  
5ar2 (mFS) This paper  
5ar3 (mFS) This paper  
5ar5 (mFS) This paper  
5cdr1 (mFS) This paper  
5cdr2 (mFS) This paper  
NBRA3.2 (mFS) This paper  
5a6 (mFS) This paper  
E14Tg2a (mES) Hooper et al 1987  
Rd2 (mES) Kalkan et al 2017  
Sox1::GFP (mES)  Starvridis et al 2003  
AFX6 (mEpiSC) This paper  
AFX33 (mEpiSC) This paper  
AF32 (mEpiSC) This paper  
OEC2 (mEpiSC) Guo et al 2009  
HNES1 (hES) Guo et al 2016  
cR-H9 (hES) Guo et al 2017  
cR-Shef6 (hES) Guo et al 2017  
Etv4/5 dKO ES This paper  
Otx2 KO ES This paper  
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hFS1 This paper  
hFS2 This paper  
hFS3 This paper  
   
   
Experimental Models: Organisms/Strains 
Mouse/CD-1 Charles River 022 
Mouse/129aa WT-Gurdon Institute N/A 
Mouse/ ROSAmT/mG Jackson Laboratory 007576 
Mouse/C57BL/6 WT-Gurdon Institute N/A 
   
Oligonucleotides 
gRNA sequences See Table S3 N/A 
Genotyping primers See Table S3 N/A 
Taqman probes and UPL primers for qRT-PCR See Table S3 N/A 
   
   
Recombinant DNA 
pPBCAG-mKO2-IP This paper N/A 
pPBCAG-GFP-IP This paper N/A 
pPBCAG-Cas9-IN This paper N/A 
pCML32 This paper N/A 
   
Software and Algorithms 



















DESeq2 v1.18.1 Love MI, Huber W, 










DeepTools  Ramírez et al., 2016 doi: 
10.1093/nar/gkw257 






MACS2 Zhang et al., 2008  






Heinz et al., 2010 http://homer.ucsd.ed
u/homer/ 
Bismark Krueger F and 




MarkDuplicates Picard tools  
Seurat v3.1.0 Butler et al., 2018 https://satijalab.org/s
eurat/ 
STAR v2.7.3a Dobin et al., 2013 https://github.com/al
exdobin/STAR 
Wiggletools Zerbino et al., 2014 https://github.com/E
nsembl/WiggleTools 
Bowtie Langmead and 
Salzberg, 2012 
 
Samtools v1.9  http://www.htslib.org/ 
FastQC v0.11.3  https://www.bioinfor
matics.babraham.ac.
uk/projects/fastqc/ 
MultiQC v1.8  https://multiqc.info/ 
Methpipe Song Q, et al., 2013 http://smithlabresear
ch.org/software/meth
pipe/ 
Venny 2.1  https://bioinfogp.cn
b.csic.es/tools/venn
y/index.html 
FCS Express 7 Research  De Novo Software 
   
Other 
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1ng 8 0 0.0%
1.5ng 8 1 12.5%
2ng 11 3 27.3%
2.5ng 4 0 0.0%
3ng 11 4 36.4%




AloX 8 4 50%
AloX
+RARi 4 4 100%
Line Percentage of diploid (=40) cells Passage number
5a6 75.0 % (24/32) 19
NBRA3.2 87.1 % (27/31) 22
5ar1 64.0 % (16/25) 21
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+Act 10ng, Chir 3μM
d0 d3
C
Formative EpiSC Formative EpiSC
Formative EpiSC Formative EpiSC
FS/EpiSC















































































































































































NBRA3.2 48 8 11 1* 39.6%
5a6 20 1 2 1 15.0%






















E5.5 44 2 5 7 16.0%
E6.0 47 1 3 4 8.5%
































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































SMAD protein signal transduction
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propionate selective glutamate receptor activity
0 2  6
FS vs EpiSC(AF)
GO term enriched in AF
GO term enriched in AXR
FS vs EpiSC(AFX)
GO term enriched in AFX
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(POUHomeobox) 1E-46 0 1E-20 0 1E-37 0
Oct4-Sox2-TCF-NANOG 
(POU Homeobox HMG) 1E-44 0 1E-06 0 1E-59 0
Lhx3
(Homeobox) 1E-09 0 1E-19 0 1E-04 0.0002
Sp2
(Zf) 1E-06 0 1E-64 0 1E-08 0
Etv4
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IOtx2KO AloXR P4 Without BMP p4+1 With BMP p4+1
20.67%
FS Otx2 KO in 2iL p1
Figure S6 (Related to Figure 6)
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Cluster: 3 Size: 285
Cluster: 1 Size: 369
Cluster: 5 Size: 7398
Cluster: 6 Size: 1135
Cluster: 2 Size: 135

















































































































































































































































































































































































































































































































































































































































































































Supplemental Figure Legends 
Figure S1. Derivation of stem cell lines from formative epiblast, Related to Figure 1 
(A) Bright field image of E5.5 epiblast derived AFX and AhiX cultures. Scale bars, 200µm. (B) 
Gene expression analysis after FGF withdrawal. Three AFX cell lines (6, 27 and 33) were 
passaged without FGF and analysed by RT-qPCR. Error bars are S.D. from technical 
triplicates. (C) Immunostained images of early lineage marker expression in AFX and AhiX 
cells. Scale bars, 100µm. (D) Summary of derivation efficiency from E5.5 epiblasts in different 
concentrations of activin A. (E) RT-qPCR analysis of RAR inhibitor treated cells. AloXR 
samples established in AloX and transferred to AloXR are in orange and a line derived in AloXR 
in pink. Error bars, S.D. from technical triplicates. (F) Derivation efficiency in the absence of 
presence of RAR inhibitor. (G) Percentages of diploid cells for 4 FS cell lines. (H) Maximum 
projection of Z-stack slices of Xist RNA FISH images (red) in female FS cells. Nuclei were 
stained with DAPI (blue). Scale bar, 10µm. (I) Gene expression analysis by RT-qPCR during 
ES cell to FS cell conversion. Gene expression is relative to beta-actin. Error bars are S.D. 
from two technical replicates. (J) Flow cytometry analysis of day 4 PGCLC induction from AloX 
FS cells. (K) Analysis of day 4 PGCLC induction from AFX EpiSCs. (L) Analysis of day 4 
PGCLC induction from AFX EpiSCs adapted to culture in AloXR. (M) AloXR cells sorted for 
SSEA1 and CD61 co-expression on day 6 of PGCLC induction (left) and subject to  RT-qPCR 
analysis (right). Relative expression level to 2iL ES cells (=1) normalized to Tbp. Error bars 
represent S.D. from technical triplicates. (N) Immunostaining of AloX cell-derived PGCLC. 
Scale bars, 50µm. 
Figure S2. Lineage potency of FS cells and responsiveness to differentiation cues, 
Related to Figure 2 
(A) Flow cytometry profiles of Flk1+Ecad- mesodermal fraction of differentiated FS cells and 
EpiSCs at day 1 and day 2. (B) Cxcr4+Ecad+ endoderm fraction at day 3. Two experiments 
are shown. (C) RT-qPCR analysis after activin A and CH treatment for 3 days. AFX EpiSC 
samples at day 3 were set as 1, normalisation to 36B4 (Rplp0). Error bars represent SD from 
technical triplicates. n.d. not detected. (D) RT-qPCR analysis of T and Foxa2 expression 24 
hours after indicated doses of Fgf2 were added into AloXR culture. Error bars represent S.D. 
from technical duplicates. 
Figure S3. Blastocyst chimaera contribution by FS cells and formative epiblast, Related 
to Figure 3 
(A) Left, low contribution E9.5 chimaera produced from mKO2-labelled NBRA3.2 FS cells. 
Right, yolk sac contribution in one of the chimaeras in Fig. 3A. Scale bars, 500µm. (B) E9.5 
chimaeras from GFP-labelled 5a6 FS cells. Contributions were widespread (left) or localised 
(right). Scale bars, 500µm. (C) E9.5 chimaeras from GFP-labelled 5ar1 FS cells. Scale bars, 
500µm.  (D) Sagittal section of embryo from C, left panel, with widespread contribution of GFP 
positive cells. Scale bar, 200µm. (E) Summary of FS cell chimaeras examined at E9.5. *Not 
all yolk sacs from chimaeric embryos were examined. (F) E12.5 chimaeric gonads generated 
from mKO2-labelled FS cells. Scale bars, 500µm. (G) Section of gonad from (F) stained with 
anti-Oct4 and anti-Mvh antibodies. Nuclei were stained with DAPI. (H-J). E9.5 chimaeras with 
contribution from E5.5 and E6.0 donor epiblast. Contributions were detected in the embryo 
proper and yolk sac (H), amnion (arrowhead) (I), yolk sac (J). Scale bars, 1mm. (K) Yolk sac 
section showing membrane-tdTomato positive cells in the inner layer of extraembryonic 
mesoderm. Nuclei were stained with DAPI (blue). Scale bar, 100µm. Magnified image from 
boxed region is shown as (K’). (L) Summary of post-implantation epiblast chimaeras.  
Figure S4. Whole transcriptome analysis and nodal/activin pathway activity, Related to 
Figure 4 
(A) Heatmap for top 50 differentially expressed genes (DEG) between FS cells and EpiSCs 
(AF). GO terms are shown (Benjamini value<0.05) for analysis of 200 DEG. (B) Heatmap for 
top 50 DEG  between FS cells and EpiSCs (AFX). GO term analysis as in A (Benjamini 
value<0.05). (C) Example embryo gene expression profiles of FS cell enriched genes 
identified in Fig. 4B. E5.5 epiblast cells are highlighted by the dashed circle.  (D) Heatmap of 
expression of Fgfs and Fgfrs. (E) Heatmap of Nodal pathway gene expression. (F) Heatmap 
of expression of Wnts and Fzd receptors. Colour scale in (D-F) is log2(normalised counts +1) 
from RNA-seq. (G) Cell morphologies after two days in indicated culture conditions: AloXR; 
1µM A83-01 in AloXR; 5µM SB505124 in AloXR; without activin A in 2µM XAV939 and 1µM 
BMS493. Scale bars,100µm. 
Figure S5. Chromatin landscape analysis, Related to Figure 5 
(A) GO term enrichment for genes proximal to phase specific ATAC-seq sites. Bars in blue 
have a significant Benjamini value<0.05. (B) Enumeration of bivalent domains in each cell 
type. (C) Genome browser screenshots of differential histone modifications. Lower three 
examples show formative specific bivalency. (D) Methylation at ATAC peaks in EpiLCs and 
EpiSCs (original data from Zylicz et al., 2015). (E) Related to Fig. 5G. GO term analysis 
performed against significantly expressed genes in EpiSCs or FS cells. Bars in blue have a 
significant Benjamini value<0.05. (F) Transcription factor binding motifs and P-values enriched 
in phase specific ATAC sites. 
Figure S6. Differential requirements for Etv4/5 and Otx2, Related to Figure 6 
(A) Schematic of ES cell differentiation to FS cells or EpiSCs and morphologies of Etv4/5dKO 
cells at day 2, P1 and P2.  (B) Bright field image of contracting Etv4/5dKO differentiated cells. 
(C) Immunostaining of Etv4/5dKO FS cell EB outgrowth. Neuroectoderm stained with Sox1 
(red) and Tuj1 (Blue), mesoderm with Gata4 (Green) and cTnT (blue), and endoderm with 
Ecadherin (red) and Foxa2 (Blue). DAPI stainings were shown in white. (D) Flow cytometry 
plot of endoderm differentiated Etv4/5dKO FS cells. (E) Immunostaining for Oct3/4 (green), 
Sox1 (red) and Tuj1 (Blue) after neural differentiation of Etv4/5dKO FS cells. (F) PGCLC 
induction from Etv4/5dKO FS cells analysed by flow cytometry for SSEA1-660 and CD61-PE 
and by immunostaining for Blimp1 (green), Stella (red) and Oct4 (blue). (G) Immunostaining 
of Etv4/5dKO FS cells in AloXR and after transfer to EpiSC culture (AFX) for three days. (H) 
Otx2 KO cells passaged in AloXR with or without BMP. (I) Bright field image of Otx2 KO FS 
cells re-plated in 2iL. Scale bars in (A), (B), (F), (H), (I) 100µm, (C) 250µm and (E), (G) 75µm. 
Figure S7. Human FS-like cells established from naïve ES cells and embryos, related to 
Figure 7 
(A) K-mean clustering of differential gene expression between human FS-like cells and 
conventional PSCs. (B) Gene expression heatmap for cluster 1 protein coding genes. (C) 
Expression heatmap of cluster 1 protein coding genes during naïve cell capacitation (data 
from Rostovskaya et al 2019). (D) Related to Figure 7I, FPKM values for additional selected 
naïve-formative specific genes. (E) Bar charts of differentially expressed TE families between 
formative and conventional hPSCs. (F) G-banded chromosomes from three independent 
human embryo derived FS-like cell lines.  
 
